Clinical Trial Update: Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 pilot study evaluating haploidentical natural killer cell infusions for poor-prognosis non-AML hematologic malignancies has completed. The trial examine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia
• Juvenile Myelomonocytic Leukemia
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma

Drugs mentioned

• Haploidentical natural killer cell infusion

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia | Phase 1 | Status: COMPLETED